The Moderna Vaccine IndexThese companies are selected for composition "Moderna Vaccine" because
1.developed the vaccine
2.suppliers
3.distribution chain
Weights are calculated by relative market cap.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
57.41 MXN
2.95 B MXN
16.48 B MXN
18.47 M
About Laboratorios Farmaceuticos Rovi, S.A.
Sector
Industry
CEO
Juan López-Belmonte Encina
Website
Headquarters
Madrid
Founded
1946
ISIN
ES0157261019
FIGI
BBG00RPL6PQ6
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ROVI/N is 1,304.92 MXN — it has increased by 4.71% in the past 24 hours. Watch Laboratorios Farmaceuticos Rovi, S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange Laboratorios Farmaceuticos Rovi, S.A. stocks are traded under the ticker ROVI/N.
We've gathered analysts' opinions on Laboratorios Farmaceuticos Rovi, S.A. future price: according to them, ROVI/N price has a max estimate of 1,982.46 MXN and a min estimate of 1,407.12 MXN. Watch ROVI/N chart and read a more detailed Laboratorios Farmaceuticos Rovi, S.A. stock forecast: see what analysts think of Laboratorios Farmaceuticos Rovi, S.A. and suggest that you do with its stocks.
ROVI/N reached its all-time high on Jul 31, 2024 with the price of 1,751.22 MXN, and its all-time low was 540.09 MXN and was reached on Feb 12, 2020. View more price dynamics on ROVI/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ROVI/N stock is 4.50% volatile and has beta coefficient of 0.55. Track Laboratorios Farmaceuticos Rovi, S.A. stock price on the chart and check out the list of the most volatile stocks — is Laboratorios Farmaceuticos Rovi, S.A. there?
Today Laboratorios Farmaceuticos Rovi, S.A. has the market capitalization of 61.78 B, it has increased by 3.21% over the last week.
Yes, you can track Laboratorios Farmaceuticos Rovi, S.A. financials in yearly and quarterly reports right on TradingView.
Laboratorios Farmaceuticos Rovi, S.A. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ROVI/N net income for the last quarter is 478.07 M MXN, while the quarter before that showed 401.19 M MXN of net income which accounts for 19.16% change. Track more Laboratorios Farmaceuticos Rovi, S.A. financial stats to get the full picture.
Yes, ROVI/N dividends are paid annually. The last dividend per share was 16.56 MXN. As of today, Dividend Yield (TTM)% is 1.35%. Tracking Laboratorios Farmaceuticos Rovi, S.A. dividends might help you take more informed decisions.
Laboratorios Farmaceuticos Rovi, S.A. dividend yield was 1.20% in 2024, and payout ratio reached 28.30%. The year before the numbers were 1.49% and 27.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 29, 2025, the company has 2.2 K employees. See our rating of the largest employees — is Laboratorios Farmaceuticos Rovi, S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Laboratorios Farmaceuticos Rovi, S.A. EBITDA is 4.46 B MXN, and current EBITDA margin is 27.07%. See more stats in Laboratorios Farmaceuticos Rovi, S.A. financial statements.
Like other stocks, ROVI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Laboratorios Farmaceuticos Rovi, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Laboratorios Farmaceuticos Rovi, S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Laboratorios Farmaceuticos Rovi, S.A. stock shows the buy signal. See more of Laboratorios Farmaceuticos Rovi, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.